Cargando…
Retraction: EBV Promotes Human CD8(+) NKT Cell Development
Autores principales: | Yuling, He, Ruijing, Xiao, Xiang, Ji, Li, Li, Lang, Chen, Jie, Xiong, Wei, Xiao, Yujuan, Wang, Lijun, Zhang, Rui, Zhou, Xinti, Tan, Yongyi, Bi, Yan-Ping, Jiang, Youxin, Jin, Jinquan, Tan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997102/ https://www.ncbi.nlm.nih.gov/pubmed/21151944 http://dx.doi.org/10.1371/annotation/1730f52d-2ba9-4f08-b330-47d71b31ae4a |
Ejemplares similares
-
EBV Promotes Human CD8(+) NKT Cell Development
por: Yuling, He, et al.
Publicado: (2010) -
Retracted: Role of CD4(+)T, CD8(+)T Cells, and CD4(+)T/CD8(+)T Cell Ratio in Gastric Cancer and Its Clinical Significance
por: and Biomechanics, Applied Bionics
Publicado: (2023) -
Retracted: A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy
por: and Biomechanics, Applied Bionics
Publicado: (2023) -
Retracted: CD3(+)T, CD4(+)T, CD8(+)T, and CD4(+)T/CD8(+)T Ratio and Quantity of γδT Cells in Peripheral Blood of HIV-Infected/AIDS Patients and Its Clinical Significance
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retraction: Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8(+) T Cells
por: Ye, Zhuo-peng, et al.
Publicado: (2021)